Clinical Trial Update: Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an immunomodulatory therapy using a COX-2 inhibitor in HIV-infected patients. The study aims to improve vaccination responses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Snippet

Sponsor: Dag Kvale | Conditions: HIV | Phase 2 | Status: COMPLETED